DOCTORAL: THE FREE APP FOR TUTORING IN SUPPORTIVE ORAL CARE

2018

To introduce the version 2.0 of DoctOral free app, created for tutoring medical/dental professionals (and students) in the clinical recognition of oral lesions and dental treatment planning in patients at risk of ONJ drug- related.

Medication-related osteonecrosis of the jaws. A large multicentric case-and-control retrospective review

2019

Ozone gas insufflation and infiltration for conservative surgical treatment of osteonecrosis of the jaw: preliminary results at 3 months

2018

the aim of this study was to evaluate efficacy and safety of ozone insufflation/injection in conservative surgical approaches of oNJ in two cancer patients.

GOTeC: INTERDISCIPLINARY TUMOR BOARD FOR THE DIAGNOSIS AND TREATMENTS OF HEAD AND NECK CANCERS

2018

Positive pressure irrigation (PPI) vs. passive ultrasonic irrigation (PUI), analysis to reduce vapour lock effect. Sistematic review and meta-analysis

2018

lynphoepithelial carcinoma in a HCv patient: a case report

2018

Oral Lichen Planus: a new experimental therapeutic protocol by means of oxygen-ozone mixture injection.

2019

Differential diagnosis of diffused oral mucosal pigmented lesion: a case of Dubreuilh’s melanosis

2019

A misleading infection in a psoriatic patient: a challenging diagnosis of orocutaneous leishmaniasis

2019

Optical Coherence Tomography (OCT) and Oral Potentially Malignant Disorders: critical review on potential diagnostic patterns

2022

The importance of prevention in the diagnosis and treatment of oral cancer

2018

Ozone insufflation and l-prf application in an idiopathic and recurrent case of osteonecrosis of the maxilla

2019

Surgical treatment of medication-related osteonecrosis of the jaws with addiction of L-PRF: preliminary results

2018

Malignant transformation of oral leukoplakia in oral squamous cell carcinoma: a case report.

2022

Development of OloHealth, a teledentistry platform for the ONJ prevention in Sicily: preliminary reports

2018

Interventions for treating osteonecrosis of the jaw stage III: may conservative surgical management be a viable option?

2018

Epithelial-myoepithelial carcinoma of the minor salivary glands: a case report

2018

Impact of periodontal treatment on GCF miRNAs expression changes associated with cardiovascular risk in patients with periodontitis

2022

STAFNE BONE CYST IN THE ANTERIOR MANDIBLE: AN UNUSUAL LOCATION

2017

To describe clinical features of the anterior Stafne bone cyst. To supply radiologist a guide for diagnosis and classification of Stafne bone cyst.

ONJ in osteometabolic patients: NO guilty verdict for teeth extraction

2018

The aim of this study is to evaluate retrospectively the impact of some variables on the risk of oNJ onset in osteometabolic non-cancer patients by logistic regression analyses.

Osteonecrosis of the jaw prevention in oncological patients: preliminary results from a teledentistry sicilian project

2019

Bioinformatics analysis of TP53 gene in head and neck squamous cell carcinoma patients from the cancer genome atlas

2019

PREVENTION OF THE DRUG-RELATED OSTEONECROSIS OF THE JAW (ONJ): PRELIMINARY DATA OF THE PROMaF PROTOCOL

2018

Ultrasounds effects on osteosarcoma cell line (MG63) with double frequency and direction of sonication

2019

Is resective surgery still the best practice for ONJ stage III? A case report of a conservative therapy

2017

L’odontoiatria a misura del paziente con patologia osteometabolica a rischio di osteonecrosi delle ossa mascellari da farmaci.

2016

L’osteonecrosi delle ossa mascellari (ONJ) da farmaci è una severa patologia odontoiatrica, recentemente defi nita come «una reazione avversa farmacocorrelata, caratterizzata dalla progressiva distruzione e necrosi dell’osso mandibolare e/o mascellare di soggetti esposti al trattamento con farmaci per cui sia accertato un aumentato rischio di malattia, in assenza di un pregresso trattamento radiante»1-3. I pazienti osteometabolici a rischio di sviluppare l’ONJ sono quelli sottoposti a terapia con bisfosfonati (in particolare aminobisfosfonati o Nitrogen-containing BisPhosphonate/NBP) e, più recentemente, con denosumab (anticorpo monoclonale anti-RANKL)4. Tali farmaci antiriassorbitivi carat…

Healing evaluation by means of Optical Coherence Tomography of an extraction socket with L-PRF application in a patient at ONJ risk: a case report

2016

Dual localization of oral Kaposi’s sarcoma in HIV-negative patient: a rare case report

2016

Not available

Segmental resection for the excision of two multicystic ameloblastoma

2014

Objectives. The purpose of this study was addressed at the understanding and management in the ameloblastoma treatment, performing a segmental surgical resection. Ameloblastoma represents nearly 1% of all neoplasm located  Annali di Stomatologia 2014; Suppl. 3 to n. 2: 1-41 15 in the oral cavity. In 80% of cases it could be found in the mandible, of these lesions 70% are located in the molar re- gion or the ascending ramus, 20% in the premolar region and 10% in the anterior part. It is considered as a benign neoplasm with slow growing-pattern and locally aggressive behaviour. Methods. On the basis of clinicoradiological findings, ameloblastoma is divided into 3 groups: solid or multicyst…